激素疗法与癌症风险;肿瘤医生薪酬削减;双乳切除术后乳腺X线摄影
Hormone Therapy and Cancer Risk; Oncology Pay Cut; Mammograms Post-Double Mastectomy
FDA取消了三种雌激素贴片的黑框警告;Elevar Therapeutics重新提交了组合疗法的申请;ASCO表示肿瘤医生将面临约2%的薪酬削减;印度制药设施因洪水关闭,影响了癌症药物的生产。
详细报道了多起产业动态和政策调整,涵盖药品上市、破产重组、医保支付调整等。
— News, features, and commentary about cancer-related issues.
November 6, 2026 • 2 min read
Doctors are warning not to overlook the small increase in breast cancer risk associated with certain hormonal therapies for treating menopause symptoms. (New York Times)
In related news, the FDA removed boxed warnings about breast cancer, cardiovascular disease, and dementia from the labels of three estrogen patches. (The Guardian)
Pope Leo XIV is kicking off a three-nation tour of Latin America, 3 weeks after undergoing lung cancer surgery that had put the entire trip into question. (AP)
After three rejections, the FDA will again review a new drug application for the investigational combination of rivoceranib plus camrelizumab for the first-line treatment of hepatocellular carcinoma, Elevar Therapeutics announced.
Karyopharm Therapeutics, which brought the selective inhibitor of nuclear export drug selinexor (Xpovio) to market for multiple myeloma, filed for bankruptcy and announced plans to merge with Ayrmid Ltd.
The Association for Clinical Oncology (ASCO) said oncologists treating Medicare patients will face a roughly 2% pay cut under the 2027 Physician Fee Schedule from CMS.
ASCO also said it's monitoring the potential impact on cancer care delivery after flooding by heavy monsoon rains led to the closure of a facility in India that manufactures sterile injectable generic oncology medications.
Can breath tests detect cancer? (Washington Post)
Prosecutors dropped charges against Kseniia Petrova, the Russian researcher who was detained for months when she came to the U.S. with frog embryos to be used in cancer research. (The Guardian)
Subtype-specific mutations may drive relapse risk in B-cell acute lymphoblastic leukemia, according to a report from the Children's Oncology Group. (Blood)
Women who have undergone a double mastectomy to treat ductal carcinoma in situ may not benefit from routine mammograms or other breast imaging. (UCLA Health)
More than 20,000 patients in the U.K. will trial cutting-edge blood tests to detect early-stage cancers. (The Independent)
Cancer survivors with obesity and a high genetic disposition to carry excess weight had a higher risk of second obesity-related cancers, according to a prospective cohort study. (JAMA Network Open)
A new, less-invasive swab test could make it easier and less painful to diagnose endometrial cancer. (Washington Post)
Newly approved pancreatic cancer drug daraxonrasib (Rasonque) has already generated $198 million in sales, according to maker Revolution Medicines.
The first patient to receive an mRNA vaccine designed to treat the stage II pancreatic cancer that might have killed her is thriving 7 years later. (NPR)
Surgery was linked with better survival compared with stereotactic ablative radiotherapy for early-stage non-small cell lung cancers where either approach was feasible, a target emulation trial found. (Journal of Clinical Oncology)
In patients who underwent endoscopic mucosal resections for large colorectal polyps, rectal lesions were linked to a higher likelihood of invasive cancer and recurrence compared with colonic lesions, a retrospective cohort study from Poland found. (Gut)
The American Society of Hematology developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with naturally lower circulating white blood cell counts. (Blood Advances)
来源:MedPage Today · medpagetoday.com